Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.07% | 492.59 | 1.0% | $790.42m | |
| DHR | Danaher Corp. | 0.10% | 243.49 | 0.7% | $637.27m | |
| ABT | Abbott Laboratories | 0.34% | 124.80 | 0.8% | $636.47m | |
| MDT | Medtronic Plc | 0.03% | 126.03 | 0.6% | $636.46m | |
| ISRG | Intuitive Surgical, Inc. | 0.00% | 812.57 | 2.3% | $365.61m | |
| ALGN | Align Technology, Inc. | 0.00% | 606.33 | 6.3% | $353.61m | |
| BDX | Becton, Dickinson & Co. | 0.07% | 261.12 | 1.0% | $310.67m | |
| SYK | Stryker Corp. | -0.07% | 256.95 | 1.3% | $300.39m | |
| NVCR | NovoCure Ltd. | -0.78% | 191.00 | 6.8% | $298.41m | |
| DXCM | DexCom, Inc. | 0.00% | 400.04 | 7.8% | $269.98m | |
| BSX | Boston Scientific Corp. | 0.00% | 40.91 | 1.0% | $259.36m | |
| EW | Edwards Lifesciences Corp. | 0.07% | 89.08 | 0.4% | $244.76m | |
| IDXX | IDEXX Laboratories, Inc. | 0.00% | 535.00 | 3.7% | $234.76m | |
| BAX | Baxter International, Inc. | -0.05% | 86.52 | 1.8% | $225.86m | |
| A | Agilent Technologies, Inc. | -0.11% | 134.43 | 1.6% | $216.62m |
Company Profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.